### ü´Å Pulm/CC: Diagnosis of a complicated parapneumonic pleural effusion

#### ‚úÖ True Statements
1. **Parapneumonic effusions** are pleural effusions associated with pneumonia and may be uncomplicated (sterile and free flowing) or complicated (infected or loculated).
2. **Empyema** is a severe form of complicated parapneumonic effusion characterized by infection within the pleural space.
3. All **parapneumonic effusions** are exudative, but pleural fluid characteristics help differentiate uncomplicated and complicated effusions.
4. A pleural fluid **pH less than 7.2** and **glucose level less than 60 mg/dL (3.3 mmol/L)** strongly suggest a complicated parapneumonic effusion.
5. A pleural fluid **nucleated cell count greater than 50,000/ŒºL (50 √ó 10‚Åπ/L)** and **lactate dehydrogenase (LDH) level greater than 900 U/L** suggest a complicated parapneumonic effusion.
6. The diagnosis of **empyema** requires pus on thoracentesis, a positive Gram stain, or positive cultures.
7. A postoperative **hemothorax** is typically defined as a pleural fluid hematocrit ‚â•50% of the serum hematocrit, although levels ‚â•25% may occur.
8. **Uncomplicated parapneumonic effusions** are characterized by pleural fluid pH >7.2 (often >7.4), glucose >60 mg/dL (3.3 mmol/L), and LDH <900 U/L.
9. **Key Point:** Pleural fluid characteristics of a complicated parapneumonic effusion include a high lactate dehydrogenase level, a low glucose level, and a pH less than 7.2.
10. **Key Point:** An empyema is characterized by the presence of pus on thoracentesis or a positive pleural Gram stain or culture.

#### üí¨ Extra(s)
4. In this patient, low pleural fluid pH and glucose, along with elevated LDH, support the diagnosis of a complicated parapneumonic effusion.
7. This patient‚Äôs pleural fluid hematocrit of 6% rules out hemothorax despite postoperative risk.

#### üìö Reference
Bedawi EO, Ricciardi S, Hassan M, et al. ERS/ESTS statement on the management of pleural infection in adults. Eur Respir J. 2023;61(2):2201062. PMID: 36229045 doi:10.1183/13993003.01062-2022.

#### üè∑Ô∏è Tags
#Pulm/CC #PleuralEffusion #ParapneumonicEffusion #ComplicatedEffusion #Empyema #HospitalCare

#### üÜî Question ID
PMMCQ24026

#### üïí Last Updated
February 2025

---

#### üìñ Related Text
MKSAP: Pulmonary Medicine, Pleural Disease, Pleural Effusion, Evaluation of Pleural Effusion, Pleural Fluid Analysis

---

### üìò Related Text Derivations

#### ‚úÖ Additional True Statements (from Related Text)
1. **Pleural fluid analysis** begins with assessment of appearance and determination of whether the effusion is exudative or transudative.
2. **Exudates** result from inflammation leading to increased capillary permeability, impaired lymphatic drainage, or both.
3. **Transudates** result from imbalance between hydrostatic and oncotic pressures, most commonly due to heart failure and cirrhosis.
4. **Light‚Äôs criteria** are commonly used to differentiate exudates from transudates, but up to 25% of transudates may be misclassified as exudates.
5. **Pleural fluid cholesterol** and **LDH** levels can aid in classification as exudates.
6. If infection is suspected, pleural fluid **pH, glucose, cell count, Gram stain, and cultures** should be obtained, with culture bottles inoculated at the bedside to increase yield.
7. If **malignancy** is suspected, pleural fluid should undergo cytologic analysis.
8. Pleural fluid **N-terminal pro‚ÄìB-type natriuretic peptide** can help diagnose heart failure as a cause of effusion.
9. A pleural **creatinine level** should be checked if urinothorax is suspected.
10. Pleural **amylase** helps identify effusions due to pancreatitis or esophageal rupture.
11. A pleural **triglyceride level >110 mg/dL (1.24 mmol/L)** supports a diagnosis of chylothorax.
12. **Neutrophil-predominant effusions** are usually secondary to an acute process such as parapneumonic effusion.
13. **Lymphocyte-predominant effusions (>50%)** are most often due to tuberculosis or cancer.
14. A lymphocyte count >85% suggests **tuberculosis or lymphoma**.
15. **Eosinophils >10%** in pleural fluid are most commonly caused by malignancy, followed by idiopathic and parapneumonic effusions.
16. Pleural fluid **pH <7.3** occurs in malignant effusions, complicated parapneumonic effusions, esophageal rupture, autoimmune pleuritis, and urinothorax.
17. A pleural pH <7.2 in parapneumonic effusion indicates the need for **tube thoracostomy drainage**.
18. Pleural fluid **glucose <60 mg/dL (3.3 mmol/L)** suggests rheumatoid pleurisy, complicated parapneumonic effusion, empyema, esophageal rupture, malignancy, lupus, or tuberculosis.
19. Pleural **adenosine deaminase** is elevated in most tuberculous pleural effusions (sensitivity ~90%).
20. **Pleural biopsy** provides histology and has ~50% sensitivity for mycobacterial culture in tuberculous pleural effusion.
21. Cytologic examination of pleural fluid has ~60% sensitivity for **malignancy**, higher in adenocarcinoma (84%) and lower in lymphoma, squamous cell carcinoma, and mesothelioma.
22. **Thoracoscopy** has >90% sensitivity for diagnosing malignant pleural disease.

#### üí¨ Extra(s)
4. Light‚Äôs criteria are highly sensitive but less specific, so clinical correlation is required.
21. Sending more than two pleural fluid samples for cytology offers little additional diagnostic yield.

#### üè∑Ô∏è Related Text Tags
#Pulm/CC #PleuralEffusion #PleuralFluidAnalysis #Exudate #Transudate #LightCriteria #PleuralMalignancy #PleuralTB

---

#### üñºÔ∏è Supplemental Figure(s)
<figure><img src="/mnt/data/Pleural Fluid Appearance.jpg" alt="Pleural Fluid Appearance"><figcaption>Figure: Serous pleural effusion (A), bloody pleural effusion (B), purulent pleural effusion (C), and chylous pleural effusion (D).</figcaption></figure>

#### üîä Supplemental Video(s)
<!-- None -->

#### üóæ Supplemental HTML Table(s)

<!--Table: Diagnostic Considerations Based on Pleural Fluid Appearance-->
<table>
<thead>
<tr><th>Appearance</th><th>Possible Causes</th><th>Additional Tests to Perform</th></tr>
</thead>
<tbody>
<tr><td>Bloody</td><td>Malignancy, pulmonary embolus, trauma, pneumonia, benign asbestos pleural effusion</td><td>Hematocrit: hemothorax if &gt;50% of the serum; consider aortic rupture, myocardial rupture, and injuries to hilar structures, lung parenchyma, and intercostal vessels</td></tr>
<tr><td>Milky</td><td>Chylothorax (post-trauma or lymphoma) or cholesterol effusion (associated with tuberculosis and rheumatoid arthritis)</td><td>Triglyceride level: chylothorax if &gt;110 mg/dL (1.24 mmol/L); Cholesterol level (low in chylothorax)</td></tr>
<tr><td>Yellow-green</td><td>Rheumatoid pleurisy</td><td>Serum rheumatoid factor; Pleural fluid glucose &lt;60 mg/dL (3.33 mmol/L)</td></tr>
<tr><td>Dark green</td><td>Bilothorax</td><td>Bilirubin</td></tr>
<tr><td>Dark brown/black</td><td>Long-standing hemothorax, fungal infection, malignancy</td><td>Hematocrit, cytology, fungal cultures</td></tr>
<tr><td>Purulent</td><td>Empyema</td><td>pH, glucose, lactate dehydrogenase, cell count, Gram stain, aerobic and anaerobic cultures</td></tr>
</tbody>
</table>

#### ‚úÖ True Statements (from Table: Diagnostic Considerations Based on Pleural Fluid Appearance)
1. A **bloody pleural effusion** may be due to malignancy, pulmonary embolus, trauma, pneumonia, or benign asbestos pleural effusion.
2. A **milky pleural effusion** suggests chylothorax or cholesterol effusion.
3. A **yellow-green pleural effusion** suggests rheumatoid pleurisy.
4. A **dark green pleural effusion** suggests bilothorax.
5. A **dark brown or black pleural effusion** suggests long-standing hemothorax, fungal infection, or malignancy.
6. A **purulent pleural effusion** suggests empyema.

#### üí¨ Optional Extra(s)
2. Chylothorax is typically confirmed by pleural fluid triglyceride &gt;110 mg/dL (1.24 mmol/L).
3. Rheumatoid pleurisy often has pleural glucose &lt;60 mg/dL (3.33 mmol/L).
6. Empyema workup includes Gram stain and aerobic/anaerobic cultures.

---

<!--Table: Very Common and Less Common Causes of Transudates and Exudates-->
<table>
<thead>
<tr><th>Transudates</th><th>Exudates</th></tr>
</thead>
<tbody>
<tr><td colspan="2"><strong>Very Common</strong></td></tr>
<tr><td>Heart failure</td><td>Parapneumonic effusion</td></tr>
<tr><td>Cirrhosis</td><td>Malignancy</td></tr>
<tr><td colspan="2"><strong>Less Common</strong></td></tr>
<tr><td>Nephrotic syndrome</td><td>Pulmonary embolism</td></tr>
<tr><td>Hypoalbuminemia</td><td>Tuberculosis</td></tr>
<tr><td>Unexpandable (trapped) lung</td><td>Autoimmune diseases (RA, SLE)</td></tr>
<tr><td>Peritoneal dialysis</td><td>Benign asbestos effusion</td></tr>
<tr><td>Atelectasis</td><td>Surgery (e.g., CABG)</td></tr>
<tr><td>Urinothorax</td><td>Acute pericarditis and post-cardiac injury syndrome</td></tr>
<tr><td>Constrictive pericarditis</td><td>Myocardial infarction</td></tr>
<tr><td>Pulmonary arterial hypertension</td><td>Yellow nail syndrome (lymphatic disorders)</td></tr>
<tr><td></td><td>Drugs (e.g., nitrofurantoin, dantrolene, methysergide, dasatinib, amiodarone, methotrexate, phenytoin, interleukin-2)</td></tr>
<tr><td></td><td>Sarcoidosis</td></tr>
<tr><td></td><td>Abdominal disease (e.g., pancreatitis, esophageal perforation)</td></tr>
<tr><td></td><td>Gynecologic disorders (e.g., Meigs syndrome, endometriosis, ovarian hyperstimulation syndrome)</td></tr>
<tr><td></td><td>Uremic pleural effusion</td></tr>
</tbody>
</table>

#### ‚úÖ True Statements (from Table: Very Common and Less Common Causes of Transudates and Exudates)
1. The most common causes of **transudative effusions** are heart failure and cirrhosis.
2. The most common causes of **exudative effusions** are parapneumonic effusion and malignancy.
3. Less common **transudate** causes include nephrotic syndrome, hypoalbuminemia, trapped lung, peritoneal dialysis, atelectasis, urinothorax, constrictive pericarditis, and pulmonary arterial hypertension.
4. Less common **exudate** causes include pulmonary embolism, tuberculosis, autoimmune disease, benign asbestos effusion, surgery, pericarditis, myocardial infarction, yellow nail syndrome, drugs, sarcoidosis, abdominal disease, gynecologic disorders, and uremia.

#### üí¨ Optional Extra(s)
<!-- None -->

---

<!--Table: Sensitivity and Specificity of Criteria for Exudative Pleural Effusion-->
<table>
<thead>
<tr><th>Test</th><th>Sensitivity (%)</th><th>Specificity (%)</th></tr>
</thead>
<tbody>
<tr><td>Combined Light's criteria (‚â•1 of the 3)</td><td>98</td><td>72</td></tr>
<tr><td>Ratio of pleural fluid protein to serum protein &gt;0.5</td><td>87</td><td>86</td></tr>
<tr><td>Ratio of pleural fluid LDH to serum LDH &gt;0.6</td><td>89</td><td>84</td></tr>
<tr><td>Pleural fluid LDH &gt;2/3 ULN for serum LDH</td><td>81</td><td>91</td></tr>
<tr><td>Pleural fluid cholesterol &gt;55 mg/dL (1.42 mmol/L)</td><td>67</td><td>94</td></tr>
<tr><td>Pleural fluid cholesterol &gt;55 mg/dL or pleural fluid LDH &gt;2/3 ULN</td><td>97</td><td>84</td></tr>
</tbody>
</table>

#### ‚úÖ True Statements (from Table: Sensitivity and Specificity of Criteria for Exudative Pleural Effusion)
1. Combined **Light‚Äôs criteria** are 98% sensitive and 72% specific for exudative effusions.
2. Pleural fluid protein/serum protein ratio &gt;0.5 has 87% sensitivity and 86% specificity for exudates.
3. Pleural fluid LDH/serum LDH ratio &gt;0.6 has 89% sensitivity and 84% specificity for exudates.
4. Pleural fluid LDH &gt;2/3 ULN for serum LDH has 81% sensitivity and 91% specificity for exudates.
5. Pleural fluid cholesterol &gt;55 mg/dL has 67% sensitivity and 94% specificity for exudates.
6. Either pleural fluid cholesterol &gt;55 mg/dL **or** pleural fluid LDH &gt;2/3 ULN yields 97% sensitivity and 84% specificity for exudates.

#### üí¨ Optional Extra(s)
<!-- None -->

---

<!--Table: Pleural Cell Count Findings and Associated Clinical Conditions-->
<table>
<thead>
<tr><th>Cell Type</th><th>Cell Count Finding</th><th>Clinical Conditions</th></tr>
</thead>
<tbody>
<tr><td>Erythrocyte</td><td>5000 to 10,000/ŒºL (5‚Äì10 √ó 10‚Åπ/L)</td><td>Hemothorax if pleural fluid hematocrit &gt;50% peripheral hematocrit</td></tr>
<tr><td>Nucleated cells</td><td>&gt;50,000/ŒºL (50 √ó 10‚Åπ/L)</td><td>Complicated parapneumonic effusions and empyema</td></tr>
<tr><td></td><td>&gt;10,000/ŒºL (10 √ó 10‚Åπ/L)</td><td>Simple parapneumonic effusion, acute pancreatitis, and lupus pleuritis</td></tr>
<tr><td></td><td>&lt;5000/ŒºL (5 √ó 10‚Åπ/L)</td><td>Chronic exudates (TB pleuritis and malignancy)</td></tr>
<tr><td>Lymphocytes</td><td>&gt;80%</td><td>TB, lymphoma, malignancy, RA pleuritis, sarcoidosis, late post-CABG effusions</td></tr>
<tr><td>Eosinophils</td><td>&gt;10%</td><td>Most commonly malignancy, idiopathic effusions, and parapneumonic effusions; also air or blood in the pleural space, drug-induced pleuritis, eosinophilic granulomatosis with polyangiitis, benign asbestos effusions, pulmonary embolism, parasitic disease</td></tr>
</tbody>
</table>

#### ‚úÖ True Statements (from Table: Pleural Cell Count Findings and Associated Clinical Conditions)
1. A pleural **erythrocyte** count of 5000‚Äì10,000/ŒºL suggests hemothorax if the pleural fluid hematocrit exceeds 50% of the peripheral hematocrit.
2. Pleural **nucleated cells &gt;50,000/ŒºL** suggest complicated parapneumonic effusion or empyema.
3. Pleural **nucleated cells &gt;10,000/ŒºL** suggest simple parapneumonic effusion, acute pancreatitis, or lupus pleuritis.
4. Pleural **nucleated cells &lt;5000/ŒºL** suggest chronic exudates such as tuberculosis pleuritis or malignancy.
5. **Lymphocytes &gt;80%** are associated with tuberculosis, lymphoma, malignancy, rheumatoid pleuritis, sarcoidosis, or late post‚Äìcoronary artery bypass graft effusions.
6. **Eosinophils &gt;10%** are most commonly due to malignancy, idiopathic effusions, or parapneumonic effusions; other causes include air or blood in the pleural space, drug-induced pleuritis, eosinophilic granulomatosis with polyangiitis, benign asbestos effusions, pulmonary embolism, and parasitic disease.

#### üí¨ Optional Extra(s)
<!-- None -->
